StreetAlpha.app
Home › Stocks › GMED

Globus Medical Inc (GMED)

Healthcare
$70.02
▼ −0.77%
LAST CLOSE · NOV 17

Globus Medical makes surgical implants and devices, including spinal products, used by surgeons. It last closed at $70.02 on Nov 17, down 0.77% on the day. GMED last reported earnings on Thu, Nov 5, 2026. The average 12-month price target from 6 analysts is $93.00 (+32.8% from the last close), with a high of $105.00 and a low of $78.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell). In the past 30 days there were 5 dark pool prints totaling $4.5M, the largest $1.6M.

AI Auto Pilots
Is GMED in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$3.1B
+13.4% vs a year ago
Net income
$557.6M
+31.6% vs a year ago
EPS (diluted)
$4.06
+31.4% vs a year ago
Free cash flow
$766.5M
24.4% margin
Valuation
Market cap
$9.4B
134.3M shares
P/E
17.2
Price over 12 month EPS
Price to sales
3.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$441.3M
At Sep 30
Shareholder equity
$4.8B
Buybacks
$324.0M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $958.1M$958.1MFY2021FY2022: $1.0B$1.0BFY2022FY2023: $1.6B$1.6BFY2023FY2024: $2.5B$2.5BFY2024FY2025: $2.9B$2.9BFY2025

From GMED's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · After the close (AMC)
Reported EPS
$1.23
vs $1.20 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±9.8%
Priced in before that report
Analyst consensus
Strong Buy
Based on 6 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
6firms
5 Buy1 Hold0 Sell
Each firm's latest rating on GMED in the past 90 days
Average 12-month target
$93.00
▲ 32.8% upside

Based on 6 analysts who set a price target on GMED in the past 90 days. The average target is $93.00, with a high of $105.00 and a low of $78.00, compared with the last close of $70.02.

Low $78.00Avg $93.00High $105.00
Blue marker: last close $70.02
Highest target$105.00
Average target$93.00
Lowest target$78.00
Latest rating changes
Truist SecuritiesTarget lowered
Nov 9Buy$100 → $90
Canaccord GenuityMaintained
Nov 6Buy$105
Wells FargoTarget raised
Nov 6Buy$99 → $100
NeedhamMaintained
Nov 6Buy$100
BMO CapitalDowngrade
Nov 6Hold$78
DateFirmActionRatingPrice target
Nov 9Truist SecuritiesTarget loweredBuy$100 → $90
Nov 6Canaccord GenuityMaintainedBuy$105
Nov 6Wells FargoTarget raisedBuy$99 → $100
Nov 6NeedhamMaintainedBuy$100
Nov 6BMO CapitalDowngradeHold$78
Loading…

Technical Analysis

GMED · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 11% below its 20 day and 9% below its 50 day average. It is 18% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39), near oversold. The nearest support is the 52 week low at $69.49, and the nearest resistance the Pivot at $70.15.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 4.5%/day
Key levels
$101.4052 week high+44.8%
$82.50200 day average+17.8%
$78.53100 day average+12.2%
$77.8620 day average+11.2%
$76.89Swing high (Sep 14)+9.8%
$76.3050 day average+9.0%
$70.81Pivot R1+1.1%
$70.15Pivot+0.2%
$70.02Last close
$69.4952 week low−0.8%
$69.36Pivot S1−0.9%
Indicators
RSI (14)38.96Weak, oversold below 30Neutral
MACD-1.72Below its signal lineBearish
Stochastic4.9Near the bottom of its rangeOversold
ADX (14)23.0Weak trend
Williams %R-97.2Oversold below −80, overbought above −20Oversold
CCI (20)-134.2Oversold below −100, overbought above 100Oversold
Rate of change−12.0%Change over 10 sessionsBearish
ATR (14)$3.15Typical daily range, 4.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GMED

What happened before

See how GMED did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow GMED usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How GMED has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in GMED in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
5
Notional
$4.5M
Largest print
$1.6M
Loading…

GMED Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲317 buying vs 262 selling
  • ●Held by funds -0.4 pts
  • ▲Funds holding +12
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding614602+2.0%
In funds' top 1011110.0%
Held by funds89.0%89.3%−0.4 pts
New / increased87 / 23075 / 251−2.8%
Reduced / sold out192 / 70178 / 88−1.5%
Put/call ratio2.160.11+1910.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GMED institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GMED is in one of them and how their past GMED trades turned out.

GMED in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GMED in an article yet. Here's the latest on the wider market.

GMED Congress Trades

All congress trades →
Trades, 12 months
3
Buys
3
100%
Sells
0
0%
People
1
Last filed Oct 12
Who traded GMED · since 2015
Latest 5 filings of 25
$1K – $15KTraded Sep 3, 2026Filed Oct 12, 2026
$15K – $50KTraded Aug 19, 2026Filed Sep 11, 2026
$1K – $15KTraded Mar 3, 2026Filed Apr 7, 2026
$1K – $15KTraded Jul 10, 2025Filed Aug 13, 2025
Lisa McClainSell (partial)
$1K – $15KTraded Jun 24, 2025Filed Aug 13, 2025
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KSep 3, 2026Oct 12, 202639 d
Gilbert CisnerosD · CABuy$15K – $50KAug 19, 2026Sep 11, 202623 d
Gilbert CisnerosD · CABuy$1K – $15KMar 3, 2026Apr 7, 202635 d
Lisa McClainR · MISell$1K – $15KJul 10, 2025Aug 13, 202534 d
Lisa McClainR · MISell (partial)$1K – $15KJun 24, 2025Aug 13, 202550 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Globus Medical

Globus Medical is a medical device company based in Audubon, Pennsylvania. It makes surgical implants and devices, including spinal products such as cervical artificial discs, spinal cord stimulation systems, and a scoliosis correction system, along with human tissue products used in surgery. Its products are used by surgeons in the United States and in other countries, and each must meet the rules of the regulators where it is sold.

Headquarters
Audubon, PA
Founded
2003